retatrutide trial update october 2025 vs Mounjaro vs Ozempic: 2026 Data Is Decisive Retatrutide approval: FDA status, clinical

In this episode, we explore the use of GLP-1 therapy for weight management beyond diabetes, including who may benefit and who should avoid it.

The conglomerate has a presence across the pharma value chain from manufacturing to diagnostics and medical devices

Compare Ozempic, Wegovy, Mounjaro, and Zepbound, including side effects, dosing, and safety.

Vegan | Non-GMO | Gluten-Free | No Artificial Additives

Ro first integrated directly with Novo Nordisk in April 2025 and has been a key part of the manufacturer's direct-to-patient expansion to date.

PlexusDx provides personalized guidance on safe, monitored GLP-1 use